Published • loading... • Updated
Health Canada approves drug that treats hot flashes for use by breast cancer patients
The non-hormonal drug cut daily hot flashes and night sweats in a 395-patient trial, giving women on endocrine therapy another option.
- Health Canada expanded market authorization for Elinzanetant, also known as Lynkuet, to treat moderate to severe hot flashes in breast cancer patients, effective Friday.
- Breast cancer patients often endure endocrine therapy for up to 10 years, causing debilitating vasomotor symptoms; Dr. Christine Brezden-Masley of Sinai Health noted patients previously lacked effective options because traditional hormone replacement therapy is generally unsuitable.
- The Phase 3 OASIS-4 trial, sponsored by Bayer, studied 395 women aged 18 to 70 experiencing at least 35 weekly hot flashes, with participants taking Elinzanetant reporting significant decreases in daily symptoms and sleep disturbances compared to placebo.
- Toronto hospital administrator Laurie Legere, 47, described her hot flashes as "really disruptive" to work and sleep; she has already secured a prescription for Elinzanetant after finding previous off-label treatments ineffective.
- Dr. Dave Cescon of Princess Margaret Cancer Centre stated the approval "will be very helpful" for patients whose symptoms were historically unaddressed, though a Bayer spokesperson noted on Monday that the drug is not currently publicly funded in Canada.
Insights by Ground AI
10 Articles
10 Articles
NiagaraFallsReview.ca+2 Reposted by 2 other sources
Cambridge ibogaine ritual death ‘unusual,’ but Health Canada tracking drug harms since 2015
Waterloo Regional Police are investigating the rare death of a man in Cambridge after an ibogaine experience. The psychoactive drug has been on Health Canada's radar against unauthorized use for 11 years.
·Niagara Falls, Canada
Read Full Article
Health Canada approves drug to treat hot flashes and night sweats in breast cancer patients
Elinzanetant, also known by the brand name Lynkuet, has shown effectiveness in reducing hot flashes and night sweats in patients whose estrogen-suppressing treatment has put them into menopause
·Toronto, Canada
Read Full Article
Ckpg Today+5 Reposted by 5 other sources
Health Canada approves drug that treats hot flashes for use by breast cancer patients
TORONTO — Health Canada has authorized a drug to treat moderate to severe hot flashes and night sweats in breast cancer patients. Elinzanetant, also known by the brand name Lynkuet, was first approved in July 2025 to treat the symptoms in women going ...
·Prince George, Canada
Read Full ArticleCoverage Details
Total News Sources10
Leaning Left5Leaning Right1Center4Last UpdatedBias Distribution50% Left
Bias Distribution
- 50% of the sources lean Left
50% Left
L 50%
C 40%
Factuality
To view factuality data please Upgrade to Premium
